Stockreport
Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors [Yahoo! Finance]
Last illumina, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations: illumina.com/company/investor-information.html
sequencing and array-based technologies, today announced changes to its Board of Directors. Scott Gottlieb , MD, has been elected non-executive Chair of Illumina's Board. Dr. Gottlieb has served on the Board of Directors since 2020. Additionally, Keith Meister , founder, Managing Partner, and Chief Investment Officer of Corvex Management, will join the Board of Directors on March 28, 2025 Stephen MacMillan , Chairman, President, and CEO of Hologic, who joined the Illumina Board in June 2023 , has decided to retire from the board in preparation for the company's upcoming annual meeting of shareholders. "I'm honored to accept this role at Illumina, a company at the forefront of our rapidly evolving industry, whose groundbreaking innovations continue to transform patient opportunities and shape the field of genomics," Dr. Gottlieb said. "I extend our gratitude to Steve for his dedication and commitment to Illumina, and I look forward to continuing to collaborate with the board and mana
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | ILMN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
ILMN alerts
ILMN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
ILMN alerts
High impacting Illumina, Inc. news events
Weekly update
A roundup of the hottest topics
ILMN
NEWS
NEWS
- Illumina To Webcast Upcoming Investor Conference[PR Newswire]
- Illumina (NASDAQ:ILMN) had its price target raised by analysts at JPMorgan Chase & Co. from $105.00 to $130.00. They now have a "neutral" rating on the stock.[MarketBeat]
- Illumina (NASDAQ:ILMN) had its "underweight" rating reaffirmed by analysts at Barclays PLC.[MarketBeat]
- Illumina (NASDAQ:ILMN) had its "hold (c-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.[MarketBeat]
- Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually [Yahoo! Finance][Yahoo! Finance]
- More
ILMN
SEC Filings
SEC Filings
- 12/16/25 - Form 4
- 12/12/25 - Form 144
- 12/9/25 - Form 4
- ILMN's page on the SEC website
- More